Bellevue Group’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
FLAM
GF
B
Bellevue Group's NEO Position: Q1 2026 in Review
Bellevue Group sold out of NeoGenomics (NEO) in Q1 2026, closing a stake of 278,286 shares — an estimated $3.27M sold.
Bellevue Group first reported a position in NEO in Q2 2020 and held it in 15 quarters. The position peaked at $38M in Q1 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.
- Bellevue Group reported no remaining NeoGenomics position as of Q1 2026 after selling out during the quarter.
- Bellevue Group sold 278,286 NeoGenomics shares in Q1 2026, an estimated $3.27M.
- Bellevue Group first reported a position in NeoGenomics in Q2 2020 and held it in 15 quarters.
- Bellevue Group's NeoGenomics position peaked at $38M in Q1 2021.
- 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.
Based on Bellevue Group's 13F filing for Q1 2026, filed 15 May 2026.